Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Globally, pressure is increasing for healthcare systems to deliver on the promise of genomic medicine to improve patient well-being. Although primary care is the ideal setting for leading this effort, ...